Hairy cell leukemia

Hairy cell leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hairy cell leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hairy cell leukemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hairy cell leukemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hairy cell leukemia

CDC on Hairy cell leukemia

Hairy cell leukemia in the news

Blogs on Hairy cell leukemia

Directions to Hospitals Treating Hairy cell leukemia

Risk calculators and risk factors for Hairy cell leukemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Vamsikrishna Gunnam M.B.B.S [2] James Nasr[3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Synonyms and keywords: Leukemic reticuloendotheliosis; Reticuloendotheliosis leukemia; Histiocytic leukemia; Malignant reticulosis; Lymphoid myelofibrosis

## Overview

[edit | edit source]

## Historical Perspective

[edit | edit source]

## Classification

[edit | edit source]

## Pathophysiology

[edit | edit source]

## Causes

[edit | edit source]

## Differentiating Hairy cell leukemia from other Diseases

[edit | edit source]

## Epidemiology and Demographics

[edit | edit source]

## Risk Factors

[edit | edit source]

## Screening

[edit | edit source]

## Natural History, Complications and Prognosis

[edit | edit source]

## Diagnosis

[edit | edit source]

Diagnostic Study of Choice | Staging | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

## Treatment

[edit | edit source]

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

## Case Studies

[edit | edit source]

Case#1

## Related chapters

[edit | edit source]

* Annexin A1

## External Links

[edit | edit source]

* National Cancer Institute

Template:Hematology

* v
* t
* e

Myeloid Hematological malignancy/leukemia histology (ICD-O 9590-9989, C81-C96, 200-208)

CFU-GM/
and other granulocytes|

Template:Navbox subgroup

MEP|

Template:Navbox subgroup

CFU-Mast|

Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis)

Multiple/unknown|

AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) * MP (Myelofibrosis) * Acute biphenotypic leukaemia

See also hematology, lymphoid malignancy

de:Haarzellleukämie it:Tricoleucemia nl:Haarcelleukemie fi:Karvasoluleukemia sv:Hårcellsleukemi

Template:WikiDoc Sources
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template